Marissa Brittenham, the Chief Strategy Officer of Surgery Partners, Inc. (NASDAQ:SGRY), has recently sold shares in the company. According to a filing with the Securities and Exchange Commission, ...

KBC Group NV lifted its stake in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 66.1% in the fourth quarter, according ...

Shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from ...

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Surgery Partners has received an acquisition offer the could take the public company private. Boston-based Bain Capital Partners has made an offer to purchase all outstanding shares of the company for ...

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Surgery Partners, Inc. (NASDAQ:SGRY), a prominent player in the healthcare services sector with a market capitalization of $3.26 billion, has been making waves in the market with its focus on ...

David T. Doherty, the Chief Financial Officer of Surgery Partners, Inc. (NASDAQ:SGRY), has recently sold a portion of his holdings in the company. According to a filing submitted to the Securities and ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Private equity firm Bain Capital plans to fully acquire Surgery Partners, one of the five largest operators of ambulatory surgery centers, for $3.2 billion.